Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in UNCY held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Vivo Capital, LLC | 1.8M | $11.8M | 0.0% | 0.749% | 0.98% |
| 2 | MILLENNIUM MANAGEMENT LLC | 1.4M | $9.2M | +37.9% | 0.585% | 0.01% |
| 3 | Octagon Capital Advisors LP | 1.0M | $6.6M | 0.0% | 0.418% | 0.73% |
| 4 | Nantahala Capital Management, LLC | 939K | $6.2M | 0.0% | 0.393% | 0.32% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 811K | $5.3M | β | 0.339% | 0.00% |
| 6 | GREAT POINT PARTNERS LLC | 797K | $5.2M | 0.0% | 0.333% | 1.28% |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 598K | $3.9M | +1067.9% | 0.250% | 0.00% |
| 8 | Logos Global Management LP | 474K | $3.1M | 0.0% | 0.198% | 0.16% |
| 9 | CITADEL ADVISORS LLC | 345K | $2.3M | +28.1% | 0.144% | 0.00% |
| 10 | Integral Health Asset Management, LLC | 225K | $1.5M | β | 0.094% | 0.09% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 204K | $1.3M | +18.9% | 0.085% | 0.00% |
| 12 | MORGAN STANLEY | 188K | $1.2M | +304.0% | 0.079% | 0.00% |
| 13 | MARSHALL WACE, LLP | 155K | $1.0M | β | 0.065% | 0.00% |
| 14 | Dauntless Investment Group, LLC | 147K | $968K | +64.5% | 0.061% | 2.58% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 143K | $940K | β | 0.060% | 0.00% |
| 16 | BNP PARIBAS ARBITRAGE, SA | 120K | $787K | +19.8% | 0.050% | 0.00% |
| 17 | DIADEMA PARTNERS LP | 106K | $698K | β | 0.044% | 0.22% |
| 18 | VANGUARD FIDUCIARY TRUST CO | 101K | $665K | β | 0.042% | 0.00% |
| 19 | Diametric Capital, LP | 80K | $529K | β | 0.034% | 0.14% |
| 20 | STATE STREET CORP | 80K | $527K | +22.7% | 0.034% | 0.00% |
| 21 | CANTOR FITZGERALD, L. P. | 75K | $494K | -62.5% | 0.031% | 0.02% |
| 22 | ACUTA CAPITAL PARTNERS, LLC | 58K | $381K | -3.4% | 0.024% | 0.27% |
| 23 | Seven Fleet Capital Management LP | 56K | $367K | β | 0.023% | 0.12% |
| 24 | BARCLAYS PLC | 50K | $329K | +62400.0% | 0.021% | 0.00% |
| 25 | NORTHERN TRUST CORP | 36K | $236K | 0.0% | 0.015% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in UNCY β a direct measure of their conviction.
Filings activity in UNCY during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 50 | +47% | 3.90% | +1.17 pp | $68M | +43% |
| Q4 2025 | 34 | +13% | 2.73% | +1.15 pp | $47M | +72% |
| Q3 2025 | 30 | +50% | 1.58% | +0.16 pp | $27M | +12% |
| Q2 2025 | 20 | 35% | 1.42% | 0.88 pp | $25M | 38% |
| Q1 2025 | 31 | +0.0% | 2.30% | 0.52 pp | $40M | 19% |
| Q4 2024 | 31 | +3.3% | 2.82% | +1.72 pp | $49M | +157% |
| Q3 2024 | 30 | +20% | 1.10% | +0.55 pp | $19M | +100% |
| Q2 2024 | 25 | β | 0.55% | β | $10M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying UNCY stock.
Based on Q1 2026 13F filings, institutional ownership of Unicycive Therapeutics, Inc. stands at 3.9%, held across 50 reporting institutions.
Vivo Capital, LLC is the largest reported institutional holder of UNCY, with approximately 1,789,916 shares worth $0.01B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of UNCY, including MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC.
Our composite Smart Money Score for UNCY is 82 out of 100 (Strong Smart Money). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
19 institutions opened new positions in UNCY during Q1 2026, while 3 fully exited. 26 added to existing positions and 5 trimmed.
UNCY institutional ownership rose by 1.17 percentage points quarter-over-quarter, with a net change of +16 holders.
The top 10 institutions account for 81.5% of all reported 13F value in UNCY, and the top 25 account for 97.1%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Unicycive Therapeutics, Inc. (UNCY) Institutional Ownership